LAS VEGAS, NV — A discharge prescription for the aldosterone blocker spironolactone in patients with a low ejection fraction who had been hospitalized for heart failure was not related to their ...

A large international study has found that spironolactone, a medication for high blood pressure and heart failure, does not reduce the risk of heart-related death or hospitalizations in people with ...

Mineralocorticoid receptor antagonists have been shown to reduce mortality in patients after myocardial infarction with congestive heart failure. Whether routine use of spironolactone is beneficial ...

Please provide your email address to receive an email when new articles are posted on . In patients who had a heart attack but not left ventricular dysfunction, spironolactone did not improve a ...

During the period from January 1, 2000 to September 30, 2008, a total of 238,721 patients had received at least one diagnosis of HF. In accordance with the RAMQ's restrictions on the number of ...

Among heart attack survivors without heart failure who were on "very good" background medical therapy, routine spironolactone was no better than placebo regarding the trial's two coprimary endpoints ...